UBE2C exerts oncogenic effects on various human solid cancers including breast cancer [42], HCC [31], colon cancer [43], nasopharyngeal carcinoma (NPC) [44] and, among others. This evidence concerns the gene UBE2C and nasopharyngeal carcinoma.